US President Donald Trump's 25% tariffs on imports of steel and aluminium is the key reason for recent investor nervousness.

The top opportunities in the genomic data analysis and interpretation market segmented by end-user will arise in the pharmaceutical and biotechnology companies segment, which will gain $756.71 million ...

The agreement will enable the establishment of rebar cage assembly factories in Neom ...